Vilya logo

Vilya Funding & Investors

Seattle, WA

Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease. The company aims to create new medicines to leverage computing to make high throughput screening obsolete and cure diseases.

vilyatx.com

Total Amount Raised: $71,000,000

Vilya Funding Rounds

  • Series A

    $21,000,000

    Series A Investors

    Arch Venture Partners
    Altitude Life Science Ventures
    Menlo Ventures
    Lifeforce Capital
    Madrona Venture Group
    NVentures
  • Series A

    $50,000,000

    Series A Investors

    Arch Venture Partners
Funding info provided by Diffbot.